insights_auto
Why is GANX down 4.82%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.00
arrow_downward
-4.82%(-0.051) 1D
$1.00
arrow_upward
+0.06% (+0.00060)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.02
High
$1.10
Low
$0.97
Mkt. cap
44.50M
Avg. vol.
690.72K
Volume
586.26K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
Decatur Daily
·
25 minutes ago
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
Nacionale
·
2 hours ago
Will the S&P 500 end 2026 down for the year? It's about 65 points above zero with 27 trading days left
Honolulu Star-Advertiser
·
8 hours ago
Wall Street rout pushes S&P 500, Dow into correction
BigGo Finance
·
30 minutes ago
S&P 500 Falls for Seventh Straight Session, Enters Correction as AI Stock Rally Loses Steam
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com